ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
115.16 EUR
+0.14 (+0.12%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 20 industry peers in the Life Sciences Tools & Services industry. ILU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ILU is not valued too expensively and it also shows a decent growth rate. These ratings would make ILU suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
In the past year ILU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 11.38%, ILU belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
The Return On Equity of ILU (29.53%) is better than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.61%, ILU belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a better Profit Margin (16.39%) than 90.00% of its industry peers.
With an excellent Operating Margin value of 20.41%, ILU belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ILU has declined.
With an excellent Gross Margin value of 66.74%, ILU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILU is still creating some value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
The number of shares outstanding for ILU has been increased compared to 5 years ago.
The debt/assets ratio for ILU is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.42 indicates that ILU is not in any danger for bankruptcy at the moment.
The Altman-Z score of ILU (4.42) is better than 80.00% of its industry peers.
ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.99, ILU belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
ILU has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.42, ILU belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.42 |
ROIC/WACC1.44
WACC10.18%
2.3 Liquidity
A Current Ratio of 1.43 indicates that ILU should not have too much problems paying its short term obligations.
ILU's Current ratio of 1.43 is in line compared to the rest of the industry. ILU outperforms 55.00% of its industry peers.
A Quick Ratio of 1.12 indicates that ILU should not have too much problems paying its short term obligations.
ILU's Quick ratio of 1.12 is fine compared to the rest of the industry. ILU outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 152.02% over the past year.
The earnings per share for ILU have been decreasing by -17.93% on average. This is quite bad
ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
Based on estimates for the next years, ILU will show a very strong growth in Earnings Per Share. The EPS will grow by 24.49% on average per year.
Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 3.93% on average per year.
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 30.96 indicates a quite expensive valuation of ILU.
The rest of the industry has a similar Price/Earnings ratio as ILU.
ILU's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.76.
ILU is valuated quite expensively with a Price/Forward Earnings ratio of 26.43.
The rest of the industry has a similar Price/Forward Earnings ratio as ILU.
The average S&P500 Price/Forward Earnings ratio is at 23.96. ILU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.96 | ||
| Fwd PE | 26.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILU is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ILU is valued a bit cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.61 | ||
| EV/EBITDA | 18.35 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ILU may justify a higher PE ratio.
ILU's earnings are expected to grow with 33.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y33.86%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (12/11/2025, 7:00:00 PM)
115.16
+0.14 (+0.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.82%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap17.60B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target105.63 (-8.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)6.5%
PT rev (3m)8.45%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)2.73%
EPS NY rev (1m)1.32%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.96 | ||
| Fwd PE | 26.43 | ||
| P/S | 4.81 | ||
| P/FCF | 20.61 | ||
| P/OCF | 18.37 | ||
| P/B | 8.66 | ||
| P/tB | 19.76 | ||
| EV/EBITDA | 18.35 |
EPS(TTM)3.72
EY3.23%
EPS(NY)4.36
Fwd EY3.78%
FCF(TTM)5.59
FCFY4.85%
OCF(TTM)6.27
OCFY5.44%
SpS23.96
BVpS13.3
TBVpS5.83
PEG (NY)0.32
PEG (5Y)N/A
Graham Number33.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.42 |
F-Score7
WACC10.18%
ROIC/WACC1.44
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year35.78%
EBIT Next 3Y17.09%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILU.DE) is 30.96 and the Price/Book (PB) ratio is 8.66.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILU.DE) is expected to grow by 96.04% in the next year.